Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-03-06 | Amended | $840,000 | $640,000 | Equity Only | 06b | SEC link |
| 2025-02-20 | New | $200,000 | $200,000 | Equity Only | 06b | SEC link |
| 2023-09-29 | New | $5,000 | $5,000 | Equity Only | 06b | SEC link |
| 2023-09-26 | New | $10,000 | $10,000 | Other | 06b | SEC link |
| Name | Role |
|---|---|
| Paul Kelly | Director, Executive |
| Traversa Sergio | Director |
| Sergio Traversa | Director |